Statin treatment and reduced risk of pneumonia in patients with diabetes

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Thorax

• Publication date

  2006-06-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.2006.062885PMID 16809409PMCID PMC2121156
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis.

  2006cited by this paper
• Statin use and mortality within 180 days after bacteremia: A population-based cohort study*

  2006cited by this paper
• Difference in Risks of Allergic Reaction to Sulfonamide Drugs Based on Chemical Structure

  2006cited by this paper
• No further tests for PE required in low probability cases with a negative D-dimer test

  2006cited by this paper
• The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia

  2005cited by this paper
• Predicting cardiac arrhythmias and sudden death in diabetic users of proarrhythmic drugs.

  2005cited by this paper
• Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002.

  2005cited by this paper
• Anomalies des cellules de l'immunite naturelle et risque infectieux chez le patient diabetique

  2005cited by this paper
• Preventing pneumonia: the role for pneumococcal and influenza vaccines.

  2005cited by this paper
• Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review.

  2005cited by this paper
• Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.

  2005cited by this paper
• Accuracy of Administrative Data for Identifying Patients With Pneumonia

  2005cited by this paper
• A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense.

  2005cited by this paper
• [Alterations in natural immunity and risk of infection in patients with diabetes mellitus].

  2005cited by this paper
• Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

  2004cited by this paper
• Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis

  2004cited by this paper
• Drug-induced pulmonary infection.

  2004cited by this paper
• Statins, inflammation, and sepsis: hypothesis.

  2003cited by this paper
• Validity of the General Practice Research Database

  2003cited by this paper
• Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study.

  2002cited by this paper
• Statins as a newly recognized type of immunomodulator

  2000cited by this paper
• Postcodes as useful markers of social class: population based study in 26 000 British households.

  1999cited by this paper
• Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.

  1999cited by this paper
• Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies.

  1999cited by this paper
• Postcodes don't indicate individuals' social class

  1999cited by this paper
• Risk factors for community-acquired pneumonia in adults: a population-based case-control study.

  1999cited by this paper
• Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults.

  1999cited by this paper
• High incidence of pneumonia in elderly patients with basal ganglia infarction.

  1997cited by this paper
• Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.

  1996cited by this paper
• Risk factors for pneumonia in the elderly.

  1994cited by this paper
• Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.

  1991cited by this paper

• Lipid-lowering drug targets and lung related diseases: a Mendelian randomization study

  2024cites this paper
• The Association between Statins Intake and Risk of Post Stroke Pneumonia: A Systematic Review and Meta-analysis.

  2023cites this paper
• The Effect of Statin Use on In-Hospital Mortality in Covid-19 Patients

  2022cites this paper
• Effect of Stress Ulcers Prophylaxis, Sedative and Statin on Ventilator-Associated Pneumonia: A Retrospective Analysis Based on MIMIC Database

  2022cites this paper
• Advances in Host-Directed Therapies Against Tuberculosis

  2021cites this paper
• Could prokinetic agents protect long-term nasogastric tube-dependent patients from being hospitalized for pneumonia? A nationwide population-based case-crossover study

  2021cites this paper
• Atorvastatin in combination with conventional antimicrobial treatment of Helicobacter pylori eradication: A randomized controlled clinical trial

  2020cites this paper
• Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients

  2020cites this paper
• Statins as Host-Directed Therapy for Tuberculosis

  2020cites this paper
• Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy

  2020cites this paper
• Statin Use and the Point Prevalence of Antibiotics in Ambulatory Patients with Diabetes in the National Health and Nutrition Examination Survey (NHANES) 2003–2012

  2019cites this paper
• Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial.

  2019cites this paper
• Diabetic lung disease: fact or fiction?

  2019cites this paper
• Protective Capacity of Statins during Pneumonia Is Dependent on Etiological Agent and Obesity

  2018cites this paper
• Effect of statins in preventing hospitalizations for infections: A population study

  2018cites this paper
• Effect of statins on hospitalization risk of bacterial infections in patients with or without diabetes

  2017cites this paper
• The Use of Statins and Risk of Community-Acquired Pneumonia

  2017cites this paper
• Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

  2017cites this paper
• Statin potency and the risk of hospitalization for community‐acquired pneumonia

  2017cites this paper
• Age-Related Changes in Immunological and Physiological Responses Following Pulmonary Challenge

  2017cites this paper
• Effect of Prior Atorvastatin Treatment on the Frequency of Hospital Acquired Pneumonia and Evolution of Biomarkers in Patients with Acute Ischemic Stroke: A Multicenter Prospective Study

  2017cites this paper
• Lack of Association between Preoperative Statin Use and Respiratory and Neurologic Complications after Cardiac Surgery

  2017cites this paper
• Previous Atorvastatin Treatment and Risk of Diabetic Foot Infection in Adult Patients: A Case-control Study.

  2017cites this paper
• Association between statins and infections among patients with diabetes: a cohort and prescription sequence symmetry analysis

  2016cites this paper
• Interpretation of the evidence for the efficacy and safety of statin therapy.

  2016cites this paper
• Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them?

  2016cites this paper
• Statin use associated with a reduced risk of pneumonia requiring hospitalization in patients with myocardial infarction: a nested case-control study

  2016cites this paper
• Protocol for analyses of adverse event data from randomized controlled trials of statin therapy

  2016cites this paper
• Efecto de la administración de las estatinas en la patología crítica no cardiológica M. Ruiz-Bailén a, , J. Pérez-Valenzuela b , A. Ferrezuelo-Mata b y R.J. Obra-Cuadra b

  2016cites this paper
• Modulation of sterol biosynthesis regulates viral replication and cytokine production in influenza A virus infected human alveolar epithelial cells.

  2015cites this paper
• Methods for preventing pneumonia

  2015cites this paper
• Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults

  2015influential citation
• Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis

  2015cites this paper
• Anticholinergic Medications and Risk of Community‐Acquired Pneumonia in Elderly Adults: A Population‐Based Case–Control Study

  2015cites this paper
• Rethinking Risk for Pneumococcal Disease in Adults: The Role of Risk Stacking

  2015cites this paper
• Pleiotropic effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in pulmonary diseases: a comprehensive review.

  2015cites this paper
• Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study

  2015cites this paper
• Established Statin Use Reduces Mortality From Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis

  2015influential citation
• Prognostic impact of statin use in patients with heart failure and preserved ejection fraction.

  2015cites this paper
• The Effect of Statins Use on the Risk and Outcome of Acute Bacterial Infections in Adult Patients.

  2015cites this paper
• Reduced Risk of Poststroke Pneumonia in Thrombolyzed Stroke Patients with Continued Statin Treatment

  2015cites this paper
• Do the omeprazole family compounds exert a protective effect against influenza-like illness?

  2014cites this paper
• Role of statin on mortality outcome in pneumonia patients: A meta-analysis

  2014cites this paper
• The Effect of Statin Therapy on the Incidence of Infections: A Retrospective Cohort Analysis

  2014cites this paper
• Sepsiste Anti-İnflamatuar Bir Ajan Olarak Statin

  2014cites this paper
• Preoperative statin therapy and infectious complications in cardiac surgery

  2014cites this paper
• Statin as an Anti-Inflammatory Agent in Sepsis

  2014cites this paper
• Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohorts.

  2013cites this paper
• Risk factors for community-acquired pneumonia in adults in Europe: a literature review

  2013cites this paper
• Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers

  2013cites this paper
• The Role of Statins in Prevention and Treatment of Community Acquired Pneumonia: A Systematic Review and Meta-Analysis

  2013influential citation
• Emerging roles for cholesterol and lipoproteins in lung disease.

  2013cites this paper
• Incidence and Predictors of Hospitalization for Bacterial Infection in Community-Based Patients with Type 2 Diabetes: The Fremantle Diabetes Study

  2013cites this paper
• The immunomodulatory effects of statins in community-acquired pneumonia: a systematic review.

  2013cites this paper
• Life-threatening Infections in Medically Immunocompromised Patients

  2013cites this paper
• Association between statins and infections after coronary artery bypass grafting.

  2013cites this paper
• Statins and pneumonia: data from clinical studies

  2013cites this paper
• Statins and Sepsis Literature Review

  2013cites this paper
• Statin use and reduced cancer-related mortality

  2013cites this paper
• review pneumonia in adults in Europe : a literature Risk factors for community-acquired

  2013cites this paper
• The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study

  2012cites this paper
• Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients

  2012cites this paper
• Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis.

  2012cites this paper
• Statin use and reduced cancer-related mortality.

  2012cites this paper
• Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells

  2012cites this paper
• The Effect of Rosuvastatin in a Murine Model of Influenza A Infection

  2012cites this paper
• The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial

  2012cites this paper
• Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia

  2012cites this paper
• Essential role of monocyte chemoattractant protein-1 in gram-negative bacterial pneumonia

  2012cites this paper
• Lifestyle Interventions and Behavior Change

  2012cites this paper
• Efecto de la administración de las estatinas en la patología crítica no cardiológica

  2011cites this paper
• Previous statins treatment and risk of post-stroke infections.

  2011cites this paper
• Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: Open-label, randomized study*

  2011cites this paper
• Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials

  2011cites this paper
• Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies

  2011cites this paper
• Statins and pneumonia

  2011influential citation
• Previous statins treatment and risk of post-stroke infections.

  2011cites this paper
• Dysregulated inflammation as a risk factor for pneumonia in the elderly.

  2011cites this paper
• Report of the ‘Mechanisms of lung injury and immunomodulator interventions in influenza’ workshop, 21 March 2010, Ventura, California, USA*

  2011cites this paper
• Thromboembolic Events in the Perioperative Period

  2011cites this paper
• Effect of the administration of statins in non-cardiac critical disease

  2011cites this paper
• Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin.

  2011cites this paper
• [Effect of the administration of statins in non-cardiac critical disease].

  2011cites this paper
• Atorvastatin reduces lipopolysaccharide-induced expression of C-reactive protein in human lung epithelial cells.

  2011cites this paper
• Statins in prevention and treatment of severe sepsis and septic shock.

  2011cites this paper
• Risk of pneumonia in patients taking statins: population-based nested case-control study.

  2011cites this paper
• Statins for community-acquired pneumonia: current state of the science

  2010influential citation
• [Effect of delay statins withdrawal during admission in medical units].

  2010cites this paper
• An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998–1999 to 2005–2006

  2010cites this paper
• Statin use does not affect the outcome of acute infection: a prospective cohort study.

  2010cites this paper
• suMMarY, disCussiOn and future perspeCtives

  2010cites this paper
• Bacterial Pneumonia among HIV-Infected Patients: Decreased Risk After Tobacco Smoking Cessation. ANRS CO3 Aquitaine Cohort, 2000–2007

  2010cites this paper
• Preadmission statin use and one-year mortality among patients in intensive care - A cohort study

  2010cites this paper
• Statins in community acquired pneumonia: Evidence from experimental and clinical studies.

  2010influential citation
• Statins in Sepsis

  2010cites this paper
• Entzündung und Sepsis

  2010cites this paper
• Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice.

  2010cites this paper
• Statin Treatment and Mortality in Bacterial Infections – A Systematic Review and Meta-Analysis

  2010cites this paper
• Mechanisms of neutrophil accumulation in the lungs against bacteria.

  2010cites this paper
• Pathophysiologie der Sepsis und deren mögliche Beeinflussung durch HMG-CoA-Reduktase-Inhibitoren

  2010cites this paper